We recognize that helping patients is at the very heart of your biotherapeutic or vaccine program. Our drug substance services are designed to keep that heart beating — at the right pace and in harmony with your program goals.
With facilities in the U.S. and Canada, our drug substance manufacturing supports clients pursuing a broad array of biotherapeutics and vaccines through our diverse technology platforms.
Our capabilities, flexibility, and expertise in drug substance manufacturing ideally position us to meet your program needs from preclinical to commercial manufacturing.
Your science and our technology platforms can make for a very powerful combination for your drug substance. Whether you’re pursuing the potential offered by next-gen mRNA therapies, or leveraging the track record of traditional approaches, you’ll find the right people, processes, equipment, and technologies at Emergent CDMO to accelerate and optimize your drug substance manufacturing program.
Whether we develop your processes here at Emergent or bring in your already developed processes, we are ready to put our expertise to work for your specific IND, NDA, and BLA applications.
Upstream Manufacturing Excellence: Our manufacturing facilities are flexible and scalable with the ability to produce drug substances (depending on the technology platform) in 50L to 1000L bioreactors, 50L to 4000L single-use bioreactors, and 10L to 4000L fermenters.
Downstream Processing Excellence: Capitalizing on best-in-class equipment, single-use containers, chromatography columns, and filtration that can accommodate the methods, technologies, and scales needed for product recovery and purification to support production up to 4000L.
.jpg)
| Technologies | Scale | Downstream Processing |
|---|---|---|
|
|
|
|
|
|
Before your manufacturing method is transferred to our Drug Substance manufacturing teams, our Process and Analytical Development teams work together and with you to develop phase-appropriate testing and production processes to maintain the integrity of your molecule.
Learn more about our process development approach to technology transfer.
If you are interested in working with Emergent, want to find out more information about our CDMO services, or would like to have us contact you for any reason, please use this web form to send us your information or questions.